TCL Archive Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent April 29, 2011
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Natcher Subcommittee Objects To Budget Reductions, Squeeze From DeVita Details On Programs Being Cut March 15, 1985
